| Breast cancer blog from medicineworld.org |
| Put this feed on your website |
| Description: |
Breast cancer blog from medicineworld.org adds a personal touch to the stories related to breast cancer. This breast cancer blog brings you stories of hope, stories of survivors and latest news and research related to breast cancer. |
| Format: |
RSS 2.0 |
| Url: |
http://medicineworld.org/stories/rss/breast-cancer-blog.xml |
| |
| Latest headlines |
Breast cancer blog from medicineworld.org
|
African ancestry linked to high-risk breast cancer
Fri, 23 Jul 2010 13:06:29 GMT
A newly released study finds that African ancestry is associated with triple-negative breast cancer, a more aggressive type of cancer that has fewer therapy options. Scientists at the University of Michigan Comprehensive Cancer Center observed that, among women with breast cancer, 82 percent of African women were triple negative, 26 percent of African-Americans were and 16 percent of white Americans were........
|
Changing the cancer cell to respond to tamoxifen
Fri, 23 Jul 2010 13:06:29 GMT
Using a small molecule decoy, researchers funded by the Samuel Waxman Cancer Research Foundation have managed to block protein interactions and induce epigenetic reprogramming in human and mouse breast cancer cells, essentially changing the gene expression of breast cancer cells to behave in a more normal manner. The research illustrates what may perhaps become an effective targeted epigenetic treatment in breast cancer. Interestingly, the targeted therapy showed exciting results in triple-negative breast cancer cells, reverting their function and appearance, and sensitizing them to tamoxifen and retinoids........
|
Fish oil may reduce risk of breast cancer
Fri, 23 Jul 2010 13:06:29 GMT
A recent report in Cancer Epidemiology, Biomarkers and Prevention, a journal of the American Association for Cancer Research, adds to the growing evidence that fish oil supplements may play a role in preventing chronic disease. Scientists at the Fred Hutchinson Cancer Research Center in Seattle, Wash., led by Emily White, Ph.D., a member of the public health sciences division, asked 35,016 postmenopausal women who did not have a history of breast cancer to complete a 24-page questionnaire about their use of non-vitamin, non-mineral "specialty" supplements in the Vitamins and Lifestyle (VITAL) cohort study........
|
Revolutionary therapy slows advanced breast cancer
Fri, 23 Jul 2010 13:06:29 GMT
A novel treatment designed to attack tumors in patients with a genetic mutation in either BRCA1 or BRCA2, slowed tumor growth in 85 percent of advanced patients with breast cancer treated in a small study, scientists report in the July 6 issue of the Lancet "That is really an enormous response rate in a population of patients who have received a median of three previous therapies," says co-author of study Susan M. Domchek, MD, associate professor of Medicine, University of Pennsylvania School of Medicine, and director of the Cancer Risk Assessment Program at Penn's Abramson Cancer Center........
|
Polarized arguments about breast screening
Fri, 23 Jul 2010 13:06:29 GMT
Polarised arguments about the benefits and harms of breast screening are not helping women to make an informed decision, argues a senior doctor on bmj.com today. Klim McPherson, Professor of Public Health Epidemiology at the University of Oxford looks at the evidence and calls for dispassionate analysis of all available data........
|
Reduce number of breast biopsies
Fri, 23 Jul 2010 13:06:29 GMT
By combining two relatively inexpensive technologies based on sound and light waves, scientists hope to lower the rate at which women undergo breast biopsies for suspicious lesions. Results of the study on ultrasound-guided optical tomography are reported in the online edition and the August print issue of Radiology.......
|
Hormonal drugs minimize surgery in breast cancer
Fri, 23 Jul 2010 13:06:29 GMT
A nationwide study has confirmed the benefit of giving estrogen-lowering drugs before surgery to patients with breast cancer. The therapy increased the likelihood that women could undergo breast-conservation surgery, also called lumpectomy, instead of mastectomy. The study's chair, Matthew J. Ellis, MD, PhD, the Anheuser-Busch Endowed Chair in Medical Oncology and a breast cancer specialist with the Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, will present the findings June 7 at the annual meeting of the American Society of Clinical Oncology........
|
Whole body MRI ifor breast cancer spread
Fri, 23 Jul 2010 13:06:29 GMT
Whole body magnetic resonance imaging (MRI) should be the imaging modality of choice for the detection of breast cancer metastases (when the cancer has spread beyond the breast) as it is highly accurate and can detect bone metastases while a patient is still asymptomatic (shows no symptoms), as per a research studyto be presented at the ARRS 2010 Annual Meeting in San Diego, CA........
|
Childhood body size affects future breast cancer
Fri, 23 Jul 2010 13:06:29 GMT
Thinner girls appears to be at higher risk of breast cancer. Scientists writing in BioMed Central's open access journal Breast Cancer Research observed that girls who were leaner at age seven were at higher risk of cancer during the later part of life. Jingmei Li worked with a team of scientists from the Karolinska Institutet, Sweden, to study the relationships between childhood body size and tumour characteristics in a group of 2,818 Swedish patients with breast cancer and 3,111 controls. She said, "Our main finding was that a large body type at age seven years was linked to a decreased risk of postmenopausal breast cancer. Eventhough strongly linked to other known risk factors such as age of menarche, adult BMI and breast density, size at age seven years remained a significant protective factor after adjustment for these other issues"........
|
Breast cancer and anthracyclines
Fri, 23 Jul 2010 13:06:29 GMT
An international team of scientists has discovered a new way of detecting which patients with breast cancer are going to respond best to chemotherapy that includes anthracycline antibiotics*. The research, presented at the seventh European Breast Cancer Conference (EBCC7) in Barcelona today (Thursday), is important because, until now, there was conflicting evidence about the best way of predicting response to anthracyclines and it was unclear whether any of the known biomarkers, such as the genes HER2 and TOP2A, were accurate indicators of response to these drugs........
|
|
